Recently published research from Global Markets Direct, "Avanir Pharmaceuticals, Inc. - Product Pipeline Review - 2014", is now available at Fast Market Research
Boston, MA -- (SBWIRE) -- 03/06/2014 -- Global Market Direct's pharmaceuticals report, "Avanir Pharmaceuticals, Inc. - Product Pipeline Review - 2014" provides data on the Avanir Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Avanir Pharmaceuticals, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Avanir Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.
View Full Report Details and Table of Contents
- Avanir Pharmaceuticals, Inc. - Brief Avanir Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Avanir Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Avanir Pharmaceuticals, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Avanir Pharmaceuticals, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to Get this Report
- Evaluate Avanir Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Avanir Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Avanir Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Avanir Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Avanir Pharmaceuticals, Inc. and identify potential opportunities in those areas.
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Ampio Pharmaceuticals, Inc. - Product Pipeline Review - 2014
- Oramed Pharmaceuticals, Inc. - Product Pipeline Review - 2014
- Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2014
- Genzyme Corporation - Product Pipeline Review - 2014
- CSL Limited - Product Pipeline Review - 2014
- Array BioPharma Inc. - Product Pipeline Review - 2014
- Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2013
- Simcere Pharmaceutical Group - Product Pipeline Review - 2014
- Immunomedics, Inc. - Product Pipeline Review - 2014
- Upsher-Smith Laboratories, Inc. - Product Pipeline Review - 2014